Company Overview
Snapshot
Founded in January 2016 by Dr. Ilya Fine and Dov Fine, SafeLuna operates with 1-10 employees. The company has secured one funding round and received a grant from Interdisciplinary Center Hertziliya in June 2018.
Business overview
SafeLuna develops remote-sensing technology designed to monitor infants. Its core product non-invasively tracks a sleeping infant's pulse and heart rate, aiming to detect early signs of sudden infant death syndrome. The company serves the digital healthcare market, specifically targeting parents and healthcare providers with solutions for patient remote monitoring and home care.
Strategic signal
In March 2019, an article highlighted Israel's growing prominence in life sciences, medical technology, and biotech, specifically mentioning the emergence of startups leveraging big data, machine learning, and AI in digital health. This signals a favorable and innovative market environment for companies like SafeLuna, indicating potential for growth and strategic partnerships within a thriving digital health ecosystem.
Log in to access full profile ›Company Intelligence Q&A
- What is SafeLuna's core technology?
- SafeLuna utilizes real-time sensing technology to remotely monitor a sleeping infant's pulse and heart rate, designed to detect signs of sudden infant death syndrome without physical contact.
- When was SafeLuna founded and by whom?
- SafeLuna was founded in January 2016 by Dr. Ilya Fine and Dov Fine.
- Has SafeLuna received any grants?
- Yes, in June 2018, SafeLuna received a grant from Interdisciplinary Center Hertziliya.
- What market does SafeLuna primarily serve?
- SafeLuna primarily serves the digital healthcare market, focusing on patient remote monitoring for infants and providing solutions for parents and healthcare providers.
- What is the company's current employee size?
- SafeLuna currently has 1-10 employees.